Mark T. Bradley

Companies

• Keenova Therapeutics plcEVP, Chief Integration Officer Aug 4, 2025 to now¹
• Endo International plcChief financial officer Mar 6, 2020 to Mar 31, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKeenova Therapeutics plc4,294 shares³Jul 31, 2025
• EIEndo International plc ENDP101,477 shares⁴Mar 30, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 31, 2025Granted 4,294 shares of Keenova Therapeutics plc³
• Mar 30, 2022Shares withheld for tax 3,057 shares at $2.52 of Endo International plc⁴
• Mar 30, 2022Exercised options 10,735 shares of Endo International plc⁴
• Mar 30, 2022Exercised options 26,805 shares of Endo International plc⁴
• Mar 29, 2022Shares withheld for tax 2,544 shares at $2.52 of Endo International plc⁴
• Mar 5, 2022Shares withheld for tax 7,789 shares at $2.34 of Endo International plc⁵